ARKG

ARK Genomic Revolution Multi-Sector ETF

Down$34.48
$-0.03
(-0.09%)
As of 12:09:36 PM EDT | 12/13/19  |  Market Open

ARKG Trading Data

Open

$34.7

Low Price

$34.41

High Price

$34.84

Previous Last Price

$34.51

Bid Size

$34.47 X 300

Ask Size

$34.5 X 1200

ARKG Portfolio Data

AUM

$476,107,200

Shares

13,905

PE Ratio

0

Price / Book Ratio

4.72

Expense Ratio

0.75

Net Asset Value

$34.24

Volume

Volume

24,664

Avg. Volume (YDT)

131,252

Dollar Volume

$976,195

Weekly Avg. Volume

159,498

Monthly Avg. Volume

138,755

Quarterly Avg. Volume

106,733

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Holdings

Top 10 Holdings

ILLUMINA INC (ILMN)
9.87%
CRISPR THERAPEUTICS AG (CRSP)
9.51%
INVITAE CORP (NVTA)
7.62%
INTELLIA THERAPEUTICS INC (NTLA)
6.79%
EDITAS MEDICINE INC (EDIT)
5.97%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.13%
TELADOC HEALTH INC (TDOC)
4.1%
CELLECTIS - ADR (CLLS)
3.9%
COMPUGEN LTD (CGEN)
3.7%
VERACYTE INC (VCYT)
3.53%

Total ARKG Holdings

Total Holdings: 36

ILLUMINA INC (ILMN)
9.87%
CRISPR THERAPEUTICS AG (CRSP)
9.51%
INVITAE CORP (NVTA)
7.62%
INTELLIA THERAPEUTICS INC (NTLA)
6.79%
EDITAS MEDICINE INC (EDIT)
5.97%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.13%
TELADOC HEALTH INC (TDOC)
4.1%
CELLECTIS - ADR (CLLS)
3.9%
COMPUGEN LTD (CGEN)
3.7%
VERACYTE INC (VCYT)
3.53%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
2.96%
IONIS PHARMACEUTICALS INC (IONS)
2.88%
NANOSTRING TECHNOLOGIES INC (NSTG)
2.87%
INCYTE CORP (INCY)
2.49%
INOVIO PHARMACEUTICALS INC (INO)
2.47%
CAREDX INC (CDNA)
2.46%
GUARDANT HEALTH INC (GH)
2.19%
CODEXIS INC (CDXS)
2.13%
REGENERON PHARMACEUTICALS (REGN)
2.13%
TWIST BIOSCIENCE CORP (TWST)
1.83%
FATE THERAPEUTICS INC (FATE)
1.62%
SERES THERAPEUTICS INC (MCRB)
1.6%
CERUS CORP (CERS)
1.54%
SYROS PHARMACEUTICALS INC (SYRS)
1.51%
PACIFIC BIOSCIENCES OF CALIF (PACB)
1.44%
CELLULAR BIOMEDICINE GROUP I (CBMG)
1.37%
RUBIUS THERAPEUTICS INC (RUBY)
1.31%
PERSONALIS INC (PSNL)
1.21%
CASTLE BIOSCIENCES INC (CSTL)
1.11%
APPLE INC (AAPL)
1.02%
BRISTOL-MYERS SQUIBB CO (BMY)
0.92%
ORGANOVO HOLDINGS INC (ONVO)
0.58%
PLURISTEM THERAPEUTICS INC (PSTI)
0.41%
INTREXON CORP (XON)
0.38%
AQUABOUNTY TECHNOLOGIES (AQB)
0.16%
ARK Genomic Revolution Multi-Sector ETF (ARKG)
0%

ARKG Technicals

Alpha

1

Beta

1.93

Leverage

Long

Standard Deviation

2.58

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.79

ARKG Performance

YTD Return

43.55%

1 Year Return

23.25%

3 Year Return

91.19%

5 Year Return

61.49%

10 Year Return

71.69%

ARKG Related Articles

10 Best Performing ETFs of 2019

10 Best Performing ETFs of 2019

2019 has been an exciting year for stocks and ETFs, especially the semiconductor and real estate industries, with markets continuing…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.